Company

JenaValve Technology

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

The Only TAVR System FDA-Approved For Aortic Regurgitation.

Also known as JenaValve

Medical devices & diagnostics

Business model: B2B
Legal name: JenaValve Technology, Inc.

jenavalve.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Our mission is to raise awareness and transform the treatment of severe aortic regurgitation

Funding snapshot

Total raised: $329MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $100M2021-12-21

Funding rounds

Round, 2021: $100M2021-12-21, SEC form D sold, 17 investors
Round, 2020: $66.5M2020-01-31, SEC form D sold, 8 investors
Round, 2019: $14.5M2019-06-06, SEC form D sold, 10 investors
Round, 2018: $14.3M2018-01-23, SEC form D sold, 11 investors
Round, 2017: $9.4M2017-07-20, SEC form D sold, 14 investors
Round, 2016: $10M2016-07-29, SEC form D sold, 11 investors
Round, 2015: $26.5M2015-07-23, SEC form D sold, 13 investors
Round, 2013: $73.4M2013-07-19, SEC form D sold, 15 investors
Round, 2010: $13.5M2010-03-01, SEC form D sold, 5 investors

Products

Web: Trilogy Transcatheter Heart Valve System